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INTRODUCTION 
 
Stroke is defined as developing symptoms or and signs of 
global or focal, loss of cerebral function with symptoms lasting for 
more than 24 hours or leading to death with no apparent cause other 
than vascular origin.
(1)
 
Globally, the rate of occurrence of stroke is estimated as 400 - 
800 per lakh of population. Around 57 lakh deaths occur due to stroke 
in a year. Approximately, 1.6 crore new acute strokes are reported 
yearly.
(3)
 
Worldwide, stroke mortality is high in Eastern Europe and Asia. 
In India, the rate of occurrence of stroke is estimated as 90 - 222 per 
lakh of population. Approximately, 14 – 16 lakhs new acute strokes 
are reported yearly. 12% of them occur in the age group of less than 
40 years.In fact, it is estimated that the incidence of stroke will reach 
one million annually by the year 2050.
(6)
 
Stroke is a leading cause of long term disability in our society. 
As the longevity of the population increase, the incidence is on the 
rise. Adoption of western diet may further increase the prevalence and 
incidence of cardiovascular disease and stroke. Of the hundreds and 
thousands of stroke survivors each year, approximately 30% need 
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support for day- to-day activities  20% need  assistance with 
ambulation  and 16% require institutional care. Hence the need for 
identifying stroke risk factors to the reduce morbidity and mortality 
due to stroke.
(4)
 
 Atherosclerotic intracranial large artery stenosis accounts for 
20% of ischemic stroke. Embolism from major arteries is a common 
source of stroke. The incidence and prevalence of the condition vary 
accordingly to the population studied. It is less common in Americans 
of African descent, Northern Europeans and more common in Asians 
of China, Japan and Korea. 
In the last two decades, theadvances in diagnostic tools have 
helped us to identify the responsible mechanism in patients with 
ischemic stroke and has crucial implication in relation to targeted 
treatment and prevention. At the same time, extraordinary imaging 
technology has been introduced that allows the physician to make 
physiologic distinctions between normal, ischemic, and infarcted brain 
tissue so as to institute appropriate therapy. 
  Asian studies show, intracranial stenosis is estimated to be 30 
to 54%of all strokes in Chinese patients, 46% in Japanese, 48% in 
Singapore patients, 10-25% in Korean patients, but only 6-10% in 
whites
. (8,9)
As Hispanics, Asians and blacks constitute the majority of 
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the world’s population, it may be inferred that intracranial stenosis is 
the most common stroke mechanism worldwide.
(5)
 
Studies regarding combined intracranial & extracranial 
stenoocclusive disease  is comparitively less. Most of the studies 
which compared the intracranial and extracranial atherosclerotic 
disease are invasive. This study compares the concordance and 
discordance of extracranial and intracranial carotid artery disease in 
patients with anterior circulation ischemic stroke or carotid transient 
ischemic attack by using doppler ultra sound study which is a 
noninvasive method 
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AIM OF THE STUDY 
 
To assess the following in patients with anterior circulation ischemic 
stroke: 
1. Risk factors involved  in carotid artery stroke. 
2. Clinical profile, pattern of vascular involvement in carotid 
artery stroke 
3. Extra cranial internal carotid artery disease by carotid doppler. 
4. Intracranial carotid artery disease by transcranial doppler in 
patients who showed extracranial internal carotid artery disease. 
5. Comparing the concordance and discordance of carotid artery 
disease in extracranial and intracranial part of internal carotid 
artery. 
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Review of literature 
Stroke is a major cause of mortality, disability, and depression 
in the world. Stroke is no longer a disease of the developed world. 
Low and middle-income countries account for 85.5% of total stroke 
deaths worldwide and the number of disability adjusted life years in 
these countries was approximately seven times that in high income 
countries 
Global Stroke estimates
(6,7)
 
• 400-800 strokes per 100,000  
• 5.7 million Deaths  
• 16 million new acute strokes every year  
• 28-30 day case fatality ranges from 17%-35%  
Stroke Morbidity and Mortality in India 
• Prevalence 90-222 per 100,000  
• 102, 620 million deaths  
• 1.44-1.64 million cases of new acute strokes every year  
• 12% of strokes occur in the population aged <40 years  
 Carotid atherosclerosis is recognized as an important cause of 
stroke and a modifiable factor for the risk reduction of subsequent 
stroke.  Recently, it has been proposed that cognitive impairment may 
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result due to carotid stenosis.
(2)
 In clinical trials, carotid 
endarterectomy can now have been replaced with carotid stenting 
since it is less invasive. Remarkable successes in stroke risk reduction 
have been achieved by continuous advances in medical therapy.  
Risk Factors for Stroke (39-42) 
It can be divided into modifiable and non modifiable factors 
Non modifiable Modifiable 
Age 
Gender 
Race/ethnicity 
Family history 
Genetics 
 
 
 
 
 
 
 
 
Arterial hypertension 
Transient ischemic attacks 
Prior stroke 
Asymptomatic carotid 
stenosis 
Cardiac disease 
Aortic arch atheromatosis 
Diabetes mellitus 
Dyslipidemia 
Cigarette smoking 
Alcohol consumption 
Increased fibrinogen 
Elevated homocysteine 
Low serum folate 
Oral contraceptives 
Obesity 
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Non Modifiable Risk factors 
1) Heredity and Risk of Stroke(19-38) 
Genetic factors have been linked with the pathogenesis of 
ischemic stroke, but specific genetic variants remain largely unknown, 
and some purported genetic associations have not been replicated 
(Chinnery et al, 2010). One of the complex polyfactorial diseases of 
large and medium sized arteries, which also have interaction with 
multiple genetic and environmental factors, is atherosclerosis. 
Endothelial dysfunction, accumulation of lipids, calcium, cellular 
debris and cholesterol within the intima of the vessel is characteristic 
of atherosclerosis. This results in plaque formation on inner walls of 
the arteries and narrowing of blood vessels which results in ischemia 
and tissue hypoxia. 
(22-23)
 
Many genetic disorders significantly influence susceptibility of 
atherosclerotic cardio vascular risk. Genetics also influences the 
arterial wall property.
(24-28)
. 
A number of inherited diseases are associated with non 
atherosclerotic vasculopathies, including type IV Ehlers-Danlos 
syndrome, Marfan syndrome, Rendu-Osler-Weber disease, and 
Sturge-Weber syndrome. Familial atrial myxomas, hereditary 
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cardiomyopathies, and hereditary cardiac conduction disorders etc, 
Protein C deficiency and Protein S deficiency or antithrombin (AT), 
and homocystinuria are associated with stroke. The presence of the 
apolipoprotein epsilon-2 allele in elderly individuals and deletion of 
the gene for the angiotensin-converting enzyme may increase the risk 
for stroke, but the association with stroke subtype is unclear 
(17, 18)
 
2) Racial difference and Atherosclerotic disease involving 
cerebral arteries (9-18) 
In Caucasian, carotid bifurcation the neck is known to be among 
the favored sites for atherosclerosis. On the contrary, primary 
intracranial atherosclerotic thrombosis was believed to be a rare cause 
of stroke 
(8)
. Nonetheless, in the past decade, it was established that 
intracranial atherosclerosis accounted for a large percentage of 
ischemic stroke, especially among the Asian and the African 
American population. 
(9–12)
 
 A pathological study of the Chinese population revealed a high 
prevalence of intracranial disease, particularly in the middle cerebral 
arterial territory 
(13)
. Racial differences might, thus, condition the 
development of atherosclerosis at various sites. However, extracranial 
atherosclerosis is increasingly observed among Asian populations. 
9 
 
Some investigators propose that the changed lifestyle, particularly the 
eating habit, might determine the modification of the site of vascular 
pathology. 
(14-16) 
3) Age. 
 The incidence of stroke doubles each decade after 55 years of 
age. Half of all strokes occur in people older than 70 to 75 years. 
Overall, stroke incidence rate is 1.25 times greater in men than 
women. Men develop ischemic strokes at higher rates than women up 
to the age of 75 years.
(43) 
 The prevalence of intracranial atherosclerosis was 
demonstrated to increase with each decade of age. It was found in 
23% of those 50-59 years of age, 43% of those 60-69 years of age, 
65% of those 70-79 years of age and 80% of those > 80 years of age. 
A study conducted in the South Korean population observed that for 
every 10 years of age, the odds of intracranial disease increased by 1.2 
(44,45)
.  
 4) Sex: 
 Risk of stroke  25 to 30% greater in males. Intracranial stenosis 
is more common among men, particularly in younger age groups and 
in particular locations, such as the basilar artery.  
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Modifiable risk factors. 
1) Hypertension: 
It is the major independent modifiable risk factor for 
intracranial stenosis. Based on epidemiological studies, hypertension 
is associated with increased odds for the development of intracranial 
stenosis that ranged from 5 to 9.7 
(46, 47)
. In fact, the impact of 
hypertension as a risk factor for intracranial atherosclerosis was 
already established from autopsy studies
 (46)
. Moreover, the risk further 
increased when hypertension was associated with other risk factors.
48
. 
2) Disorders of Lipid Metabolism. 
Intracranial stenosis has been associated with dyslipidemia, 
especially elevated total cholesterol but also its various components. 
High lipoprotein is an independent marker for a greater extent of 
disease. There is actually a synergic effect between lipoprotein “a” 
and diabetes mellitus and resultant intracranial occlusive disease 
(40,49)
. 
Elevated Low Density Lipoprotein and high total cholesterol has been 
shown to be a risk factor for atherosclerosis and the development of 
intracranial stenosis.
[49]
 Lipid lowering agents definitely slow the 
progression of atherosclerosis and the development of large artery 
stenosis. 
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3) Diabetes Mellitus 
Diabetes is an independent risk factor for intracranial stenosis. 
It promotes the accelerated formation of atherosclerotic stenosis 
through a decrease in fibrinolytic activity
 (49, 50)
. Based on 
epidemiological studies, the odds ratio associated with diabetes ranges 
from 4 to 5.9 
[47, 49, 50]
. In fact, data from the Northern Manhattan 
Stroke study revealed that patients with intracranial atherosclerosis 
had a higher prevalence of diabetes (67%) when compared to those 
with extracranial atherosclerosis (60%).
(51)
 The impact of diabetes was 
also established in autopsy study done in Hong Kong 
[50]
. These 
studies, suggest   Diabetes Mellitusas the strongest risk factor for 
intracranial stenosis. 
4)Metabolic Syndrome 
Results from the Northern Manhattan Stroke Study 
[51]
 also 
demonstrated a higher prevalence of metabolic syndrome in patient 
with intracranial atherosclerosis when compared to those with extra 
cranial atherosclerosis, nonatherosclerotic stroke, and controls (62%, 
40%, and 35% respectively). Other potential though less well-studied 
factors include sickle cell disease, meningitis, cranial radiation 
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therapy, tobacco exposure, family history, and presence of extra 
cranial carotid atherosclerosis and aortic plaques 
[52]
.  
Carotid disease and stroke 
 
Anatomy of carotid system: 
    
              The common carotid arteries differ in length and in their 
mode of origin. The left arises from arch of the aorta and has thoracic 
and cervical portion. The right begins just behind the sterno clavicular 
joint at bifurcation of the innominate artery and has only cervical 
portion. 
Two  carotid arteries  arises from common carotid  artery are, 
External carotid artery, supplying the face, and the greater part of 
the neck and cranial vault 
Internal carotid artery, supplying brain and orbital cavities. It has 
extra cranial and intra cranial part. No branches for extra cranial 
portion of internal carotid artery.
(53,54)
 
Intracranial portion has several important branches 
a. Opthalmic artery 
b. Posterior communicating artery 
c. Anterior choroidal artery 
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d. Anterior cerebral artery 
e. Middle cerebral artery 
The ophthalmic artery is the first major branch arises from 
supra clinoid portion of the internal carotid artery (ICA). Occlusion 
can lead to visual symptoms, including visual loss called amaurosis 
fugax. Next branch is posterior communicating artery, supplying the 
anterior and medial portions of the thalamus. The anterior choroidal 
artery supplies portions of the basal ganglia, hippocampus, and 
posterior limb of the internal capsule. The ICA then divides into 
anterior cerebral and middle cerebral arteries. These arteries supplies 
frontal, parietal, temporal cortical and subcortical regions. 
(55-60)
 The 
carotid sinus, or carotid bulb, is a widening of a carotid artery at its 
main branch point. The carotid sinus contains sensors that help 
regulate blood pressure. The carotid artery pulse can normally be felt 
in the neck by pressing the fingertips against the side of the trachea 
against C4 spinous process. 
Clinical presentation: 
Transient Ischemic attack: 
Defined as brief episode of neurological dysfunction caused by 
a focal brain or retinal ischemia, with clinical symptoms typically 
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lasting less than 1 hour and without evidence of infarction. Transient 
Ischemic attack is an indicator of future stroke risk with 25% to 30% 
of patients having a stroke over the ensuing 5 years. The risk of stroke 
is maximum during the first week nearly 11%. 
Visual symptoms: 
Signs of carotid occlusion include transient monocular 
blindness or visual loss or dimness of vision with exercise, after 
exposure to bright light, or on assuming an upright position. The 
cardinal clinical signs of stenosis, ulcerations, and dissections of the 
internal carotid artery are TIAs. 
(80)
It is a subject of debate whether 
these are the result of fibrin platelet emboli or a reduction in blood 
flow.  
In carotid stroke the duration of vision loss is usually 1 to 5 
minutes and rarely lasts more than 30 minutes. After an episode of 
amaurosis fugax, the vision is usually fully restored, although some 
patients may have permanent vision loss caused by a retinal 
infarction.
[61]
.The internal carotid artery nourishes the optic nerve and 
retina as well as the brain. For this reason, transient monocular 
blindness occurs prior to the onset of stroke in 10 to 25 percent of 
cases of symptomatic carotid occlusion. Yet central retinal artery 
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ischemia is a relatively rare manifestation of carotid artery occlusion, 
presumably because of efficient collateral supply in the globe. 
Symptoms of Stroke: 
• Unilateral paralysis (opposite side) 
• Numbness (opposite side) 
• Language disturbance 
Aphasia  
Dysarthria  
• Visual disturbance (opposite side) 
• Monocular blindness (same side) 
 In case of occlusion distal perfusion is highly dependent on the 
configuration of the circle of Willis. For example, when the anterior 
communicating artery is very small, the ipsilateral anterior cerebral 
territory is affected as well. In extreme instances where the circle of 
Willis provides no communication to the side of an occluded carotid 
artery, thus isolating the hemisphere from other blood flow, massive 
infarction involving the anterior two-thirds or all of the cerebral 
hemisphere results. If the two anterior cerebral arteries arise from a 
common stem on one side, infarction may occur in the territories of 
both vessels. The territory supplied by the posterior cerebral artery 
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will also be included if this vessel is supplied by the internal carotid 
rather than the basilar artery.
[66-72]
 When the circulation of one carotid 
artery has been incompletely compromised, reducing blood flow in 
both the middle and anterior cerebral territories on that side, the zone 
of maximal ischemia lies between the two vascular territories 
("cortical or external watershed") or, alternatively, in the deep portions 
of the hemisphere between the territories of the lenticulo striate 
branches and the penetrating vessels from the convexity ("internal" or 
"deep watershed"). 
 The infarction in the first instance occupies a region in the high 
parietal and frontal cortex and the adjacent subcortical white matter. 
Its size depends upon the adequacy of collateral vessels. Weakness 
tends to involve the shoulder and hip more than the hand and face. 
With long-standing carotid stenosis, the cortical watershed zone shifts 
downward toward the perisylvian portions of the middle cerebral 
artery territory, even to the extent that a stroke may weaken facial 
movement or cause a nonfluent aphasia. With impaired perfusion of 
the deep watershed, infarctions of varying size are situated in the 
subfrontal and subparietal portions of the centrum semiovale
[73-76]
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Clinical and Radiological presentation:[62-67] 
The radiological presentation of carotid strokes include  
1. Cortically based territorial infarctions,  
2. Watershed zone infarct (internal or external)  
3. Subcortical infarct,  
4. Cortical and subcortical infarcts  
5. Multiple fragmented infarct 
The mechanism of stroke due to intracranial stenosis is often 
studied by the pattern of infarction on brain imaging in magnetic 
resonance imaging. Deep infarcts suggest local thrombosis at the 
origin of perforators. Complete occlusion distal to the site of stenosis 
suggests complete segmental occlusion. Single or multiple distal 
cortical infarct patterns suggest embolism from the site of proximal 
stenosis. Lastly, a border zone pattern with impaired washout is 
appears like “rosary bead” or “string of pearls” in the deep white 
matter territory of the middle cerebral artery. Often, a combined 
pattern is noted which makes a definitive determination of stroke 
mechanism a challenge. In the Asian, African and Hispanic 
populations,    White matter lesions (WML), micro bleeds, and lacunes 
which are observed in magnetic resonance imaging (MRI) are 
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assumed to be symptoms of cerebral small vessel disease (SVD). 
Initially these lesions were considered as “silent,” but recent 
longitudinal studies show that presence of these lesions significantly 
increases future risks of dementia, stroke, and mortality. Hence it was 
recommended that preventive trials should target SVD, preferably in 
its “subclinical” stage.  However, conducting a MRI to screen for 
“subclinical” lesions on recruited subjects in trials is not cost-
effective. Till date, there are no simple screening methods for SVD. 
Hence the pulsatility index (PI), derived from Transcranial Doppler 
ultrasound, has been proposed to reflect vascular resistance of small 
vessel for a long time. 
A recent case study emphasized how these may interact and 
provided in vivo evidence of the impaired washout hypothesis 
[60-65]
.  
Mechanism of Carotid disease: 
 Carotid arteries like other arteries are made up of three layers of 
tissue: 
 Intima, the smooth innermost layer 
 Media, the muscular middle layer 
 Adventitia, the outer layer 
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Intracranial arteries are composed of endothelium, smooth muscle 
cells and an extracellular matrix consisting of collagen and elastin 
fibers.
(39) 
The luminal tunica intima includes a single layer of 
endothelial cells overlying delicate connective tissue which is 
supported by a dense elastic band, the internal elastic lamina. The 
middle layer, or intima media, consists of smooth muscle cells. The 
outermost tunica adventitia is mainly composed of collagen and is 
predominantly surrounded by only cerebrospinal fluid. A cascade of 
events including macrophage recruitment and low-density lipoprotein 
accumulation results in atherosclerotic plaque formation.
(41-46)
 
The several mechanisms of ischemic stroke related to intracranial 
atherosclerosis include hemodynamic failure, in situ thrombosis from 
plaque disruption, distal thromboembolism, and perforator artery 
occlusion by plaque within the parent artery. Perforator artery 
occlusion seems to be the least frequent mechanism as most 
subsequent strokes. (91%) 
[53]
. An impaired washout concept has also 
been a proposed mechanism that results from a combination of 
hypoperfusion and distal thromboembolism 
[54]
. Thus, progressive 
arterial narrowing, plaque instability and thromboembolism, and/or 
exhausted collateral flow with impaired vasomotor reactivity are inter-
woven mechanisms that may contribute to ischemic stroke due to 
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intracranial stenosis. The carotid stenosis causes local reduction in 
cerebral blood flow. Then the alteration of cellular chemistry that are 
caused by ischemia and which lead necrosis of neuron, glia and other 
brain cells 
There is growing evidence for these specific individual 
mechanisms and their potential synergism 
[55-59]
. Thromboembolic 
mechanisms include in-situ thrombosis with resultant large artery 
occlusion, perforator (small artery) occlusion, and/or distal embolism. 
In one study, among 63 patients with middle cerebral artery stenosis 
and acute ischemic stroke, 32 showed multiple lesions in the MCA 
territory 
[57]
. The majority had perforating artery infarcts, alone or in 
combination with distal territory infarcts while a minority had border 
zone infarcts suggesting flow failure. Yet another study noted that 
60% of patients with multiple-infarction on diffusion-weighted 
imaging had micro embolic signals on TCD monitoring of the middle 
cerebral artery compared to only 6% in patients with a single 
perforator or single infarction pattern 
[60]
. Hemodynamic impairment is 
likely in patients with intracranial occlusive disease. With progressive 
stenosis, the tissue distal to the lesion may depend on collateral blood 
flow. In one study, 30% of patients with middle cerebral artery 
occlusion had impaired cerebral hemodynamics on vasomotor 
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reactivity testing 
[58]
. In a small positron emission tomography study, 
25% of those with symptomatic middle cerebral artery stenosis had 
abnormal hemodynamics 
[55]
. Using quantitative Magnetic Resonance 
Angiography to estimate vessel-specific flow among patients with 
symptomatic vertebra basilar stenosis, 16 of 50 patients had impaired 
flow
 [56]
. 
Fisher suggested that atherosclerosis was the likely pathological 
cause of occlusive carotid artery thrombosis, and he confirmed Chari’s 
earlier observation that thrombosis at this site is mostly preceded by 
plaque ulceration. This concept has subsequently been confirmed by 
other studies and carotid sinus plaque rupture has been associated with 
sites at which a thin, fibrous cap formation, as in the coronary 
circulation.
(68-72) 
Diagnosis of Carotid disease :(77-80) 
 Imaging modalities used to diagnose carotid disease are, 
i. Magnetic resonance angiography (MRA), 
ii. Computerized tomographic angiography (CTA) 
iii. Digital Subtraction Angiography (DSA) 
iv. Carotid doppler 
v. Trans Cranial Doppler (TCD) 
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 The diagnosis of intracranial stenosis has upgraded with the 
advent and availability of non-invasive vascular imaging tests.  
Magnetic resonance angiography (MRA) is a non-
invasive imaging modality which can identifies vessel anatomy, 
intracranial stenosis, and also plaque character. Contrast MRA can 
provide anatomy in a better way.  
MRA measures flow signal intensity as a function of proton 
spin, as utilized in time-of flight (TOF) MRA to visualize blood flow 
changes 
[101]
. The advantages of MRA are radiation exposure or radio 
contrast risks. MRA has sensitivity of 70% in detecting intracranial 
stenosis of >50% and 81% sensitivity in detecting intracranial 
complete occlusion. 
[101]
. 
Major disadvantages are 
1) Vulnerability to motion artifacts,  
2) Inability to distinguish between high-grade stenosis and        
occlusion  
3) It has limited role in obese, claustrophobic, or have 
implanted foreign metallic objects (i.e. pacemakers).  
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Expanding the role of MRA in detecting intracranial stenosis is 
Contrast-enhanced MRA  which uses gadolinium dye for better 
visualization of changing blood flow directions. 
 Quantitative MRA, utilizing phase-contrast techniques, has 
been used as a diagnostic tool of intravascular blood flow to diagnosis 
hemodynamic failure in posterior circulation stenosis 
[102, 103]
 and 
screen for post-procedural stenosis at sites of stents or coils. QMRA 
can also assess regional blood flow which can indicate the overall 
cerebral hemodynamic and collateral flow status. Another emerging 
MR technique is high resonance imaging (HR-MRI), capable of 
visualizing and characterizing plaque morphology and behavior, and 
discriminating from other non-atherosclerotic etiologies. Further study 
using these novel modalities may increase the diagnostic utility of 
MRA and provide valuable prognostic data. 
CT angiography (CTA): 
 It gives better anatomical delineation of vessels. CTA focuses 
on relative penetrance of contrast material within the vessels. It 
overcomes the slow flow artifact produced by MRI. It has 98% 
sensitivity and 99% specificity. Major disadvantage is risk of radio 
contrast and anaphylaxis.
(101)
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Digital Subtraction Angiography (DSA) 
Conventional catheter-based angiography remains the gold standard 
but has possibly serious risks and limited availability. Each has its 
own attributes and limitations. Besides their usefulness in the 
anatomic diagnosis of intracranial stenosis, non-invasive imaging can 
also offer critical physiologic information (such as blood flow 
characteristics) which can support in prognostication and recurrent 
stroke risk stratification 
[81]
. In comparing the efficacy of non-invasive 
imaging techniques, Digital Subtraction Angiography (DSA) is 
considered the reference standard. It provides tremendous overall 
visualization of vessel contour, anatomic localization, measurement of 
degree and length of stenosis, and assessment of collateral circulation. 
Modern DSA also includes three-dimensional reconstructed images 
from the raw data to provide even greater detail. Due to its invasive 
nature, there is a small but real risk (approximately 0.7%) of peri-
procedural neurologic injury associated with DSA [82]. The most 
serious complications like ischemic and hemorrhagic stroke,  are noted 
within 24-72 hours of the procedure. Further DSA carries the 
nephrotoxic risk associated with iodinated contrast injection and the 
potential for access-related injury (i.e. groin hematoma and limb 
25 
 
ischemia). Even now, for analyzing the cerebro vascular system and 
its branches, the gold standard is Cerebral angiography. 
 
Carotid Doppler: 
 Noninvasive ultra sound device used to evaluate blood flow 
velocity in major cerebral vessels on beat to beat basis  and is know as 
stethoscope of brain. Extra cranial carotid artery studied with carotid 
Doppler by using 8 MHz probe. It acquire images by transverse and 
longitudinal plane.
(98-100)
 
Components of ultra sound examination includes, 
 Continuous wave doppler 
B Mode to study the anatomy 
Colour flow imaging  
Power Doppler Imaging 
The colour velocity image 
Doppler velocity spectral display 
Parameters assessed, 
 PSV- Peak systolic velocity 
 EDV- End diastolic velocity 
 Intima media thickness 
 Plaque character , size, echogenicity 
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 Carotid Index 
 Degree of stenosis 
Vessels studied: 
 
Duplex Assessment of Carotid Stenosis 
The severity of luminal narrowing is determined with color Doppler 
image through careful measurement of the diameter, or area of the 
residual lumen, as seen on transverse images.  Measurement at peak 
systole is suggested, because diastolic measurements may 
overestimate luminal reduction.  Accurate measurement also depends 
on satisfactory image quality, proper instrument settings, and the 
depiction of a true cross section of the vessel.  For measurement of 
percent diameter reduction, the margins of the original arterial lumen 
Internal carotid 
artery 
Sharp systolic peak with gradual slope in late 
systole and good forward in entire diastole.  
Diastolic waveform does not touch the 
baseline.  Clear “window” in both systole and 
diastole.  Peak systolic velocity less than 125 
cms/sec or 4 K Hz. 
External carotid 
artery 
Sharp systolic peak with minimal or absent 
flow in diastole 
Common carotid 
artery 
Spectrum is a combination of internal and 
external carotid artery waveform. 
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also must be precisely defined.  The identification of the media of the 
vessel is the best means for defining the original lumen size.
(98)
  
Trans Cranial Doppler ultrasound: (TCD) (83-100) 
TCD is noninvasive and is commercially available. TCD 
ultrasonography instruments use a low-frequency 2-MHz probe to 
allow insonation through the cranium. These pulsed-wave Doppler 
instruments have an effective insonation depth range of 3.0 to 12.0 cm 
or more that can be evaluated by increments of 2 or 5 mm. At an 
insonation depth of 50 mm, the sample volume is usually 8 to 10 mm 
axially and 5 mm laterally.  
TCD probes also differ from the 4- to 10-MHz transducers used 
to monitor the progress of intraoperative neurosurgical procedures 
(Unsgaard et al., 2002). 
Four natural acoustic windows used: 
1). Trans temporal bone window:  
Segments that can be recorded in this window  
• MCA ( Prox, Mid, Distal ) 
• ACA 
• PCA ( P1 and P2 ) 
• tICA (Terminal ICA) 
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Normal blood flow direction is toward the probe in the MCA and 
away from it in the anterior cerebral artery. Depending on the position 
of the window, the probe usually has to be tilted frontally to detect 
these vessels. A posterior (or occipital) tilt of the probe enables 
insonation of the PCAs.  
2).Trans occipital window:  
Flow in the distal vertebral artery and proximal to mid-portions 
of the basilar artery can be detected in this window. Its direction is 
away from the probe in these arterial segments. 
o Vertebral arteries – 40-95 mm 
 Aim right and left for the vertebral arteries 
o Basilar artery – 70-115 mm 
3). Trans orbital Window: 
Ophthalmic artery and carotid siphon can be recorded in this 
window. Flow is towards the signal in these arteries. 
 Ophthalmic artery 
 Carotid siphon 
4).Sub mandibular Window:  
 Distal ICA (Internal Carotid Artery) Segment recorded in this 
window. Useful for the detection of ICA dissection and Chronic ICA 
occlusion 
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Vessels studied, 
 Distal Internal Carotid Artery 
 Middle Cerebral Artery 
 Anterior Cerebral Artery 
 Posterior Cerebral Artery 
 Vertebral Artery 
 Basilar Artery 
 Posterior & Anterior Communicating Arteries 
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Vessel  Depth-mm      Velocity-cm/s            Direction 
MCA      30-60 (50)  43-67 (55)   + 
ACA(A1)     60-75 (65)  39-61 (50)   - 
PCA(P1)     60-75 (70)  29-49 (39)   + 
TICA      55-65  30-48 (39)   + 
VA      60-90 (70)   28-48 (38)   - 
BA              80-120 (95)  31-51 (41)   - 
OA      40-60 (45)   16-26 (21)   + 
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TCD wave form: 
.  
Parameters calculated: 
. The pulsatility index (PI): 
PI = (Peak systolic velocity - end diastolic velocity)/mean velocity. 
 PSV- Peak systolic velocity 
 EDV- End diastolic velocity 
 MFV- Mean flow velocity 
Physical factors affecting cerebral blood flow 
• Age 
• Gender 
• Hematocrit 
• Fever 
• Hypoglycemia 
• Carbon Dioxide 
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• Heart Rate/Cardiac Output/Blood Pressure 
• Brain Activity 
Diagnostic Criteria – Stenosis 
 Increased flow velocity – generally focal 
 Disturbed flow 
Turbulence; spectral broadening 
 Covibration phenomena 
Vibration of the vessel wall & surrounding soft tissue 
 Drop in post-stenotic velocity 
 Changes in post-stenotic waveform morphology 
Prolonged systolic upstroke 
Decreased pulsatility 
 Comparison of PSV with contralateral vessel PSV 
Increased PSV >30% - suspicious 
Increased PSV >50% - definite 
 Sensitivity - 100% 
 Specificity - 97.9% 
 Positive Predictive Volume - 88.8% 
 Negative  Predictive Volume  - 94.9% 
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Diagnostic Criteria – Occlusion 
 Absence of arterial signal at expected depth 
 Presence of signals in vessels which communicate with the 
occluded artery 
 Altered flow in communicating vessels, indicating 
collateralization   
Pitfalls & Diagnostic Accuracy 
 Lack of flow signal due to an inadequate temporal window 
 Misinterpretation of hyper dynamic collateral channels   or 
AVM feeders as stenosis 
 Displacement of arteries because of a space-occupying lesion 
 Misinterpretation of physiologic variables in the circle    of 
Willis 
 Misdiagnosis of vasospasm as stenosis 
 Misinterpretation of reactive hyperemia following spontaneous 
recanalization as stenosis 
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 Applications of Transcranial Color Doppler Imaging(106) 
1. Diagnosis of intracranial vascular disease  
2. Evaluation of the hemodynamic effects of extra cranial 
occlusive disease on intracranial blood flow  
3. Detection of cerebral emboli 
4. Assessment of intracranial collateral pathways  
5. Monitoring vasospasm in subarachnoid hemorrhage  
6. Intraoperative monitoring  
7. Documentation of subclavian steal  
8. Monitoring evolution of cerebral circulatory arrest  
9. Screening of children with sickle cell disease  
   10. Evaluation of the vertebrobasilar system  
   11. Detection of feeders of arteriovenous malformations (AVMs)  
   12. Monitoring anticoagulation regimens or thrombolytic therapy  
   13. Monitoring during neuroradiologic interventions  
   14. Testing of functional reserve  
   15. Monitoring after head trauma  
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TCD in the management of Carotid disease (104-106) 
• Carotid ultrasound has high sensitivity and specificity in the 
reliable assessment of the carotid bifurcation, in patients with 
Transient ischemic attacks and in those with moderate to severe 
extra- or intracranial carotid stenosis compared to patients with 
no such findings. Trans cranial Doppler performed within 24 
hours of symptoms revealed a threefold greater risk for stroke in 
the next 90 days in patients with micro embolic signals. 
• Micro embolic signals (MES) on Trans cranial Doppler is 
considered as a marker of risk in patients with emboli of carotid 
origin.  This prompted research into optimal strategies for 
medical treatment and the timing of endarterectomy in those 
with an extracranial carotid disease. 
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Advantages of TCD: 
• TCD is relatively in expensive, noninvasive, portable and fairly 
easy to use.  
• It allows frequent repeated measurements and continuous 
monitoring. 
•  Immediate, real time detection of changes in cerebrovascular 
hemodynamics is possible.  
• It can be utilized by any medical specialty to evaluate several 
neurovascular disorders. 
• In-expensive 
• Portable 
Limitation of TCD  
 Waveforms can be obtained only in 75-80% of the patient 
population 
 Inter individual variation (observer Bias) 
 Needs skill to study all arteries and its flow pattern and 
anastomosis 
 Obesity and thick skull may increase the impedance 
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Treatment of carotid stroke (106) 
Medical treatment: 
 Aspirin  
 In long term secondary prevention of ischemic strokes, the most 
effective anti-platelet agents are 
 Clopidogrel,  
  Combination of aspirin and extended release dipyridamole, 
 Ticlopidine and Triflusal. 
Surgical Management: 
Carotid endarterectomy  as the treatment of choice for moderate and 
severe carotid artery stenosis as a secondary stroke prevention 
measure. 
• Carotid endarterectomy reduced the 5-year absolute risk of any 
stroke or death in patients with 50–69% stenosis, according to 
angiographic NASCET, and was highly beneficial in patients 
with 70–99% stenosis, but showed no benefit in patients with a 
near occlusion.  
2) Carotid stenting: In case of recurrent stenosis and in patients who 
are unfit for   Carotidendarterectomy. 
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MATERIALS AND METHODS 
This cross sectional study was conducted during Jan 2011 to 
Oct 2012 at Madras Institute of Neurology, Rajiv Gandhi Government 
General Hospital, and Chennai. 
 Patients with clinical features suggestive of stroke were enrolled 
in this study; all were subjected to CT Brain, MRI Brain and Carotid 
Doppler. 
Inclusion Criteria: 
1. All the patients with clinical feature suggestive of stroke. 
2. Imaging showing ischemic infarct in the anterior 
circulation. 
3. Carotid Doppler showing atherosclerotic carotid artery 
disease  
4. Patients with anterior circulation TIA. 
Exclusion Criteria: 
1. All hemorrhagic strokes. 
2. Posterior circulation stroke 
3. Patients without carotid artery disease on carotid doppler 
4. Patients with cardiac disease 
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 Detailed history regarding age , sex , address, occupation, 
complaints, evolution of symptoms, previous history of Transient 
ischemic attacks, amaurosis fugax, Diabetes mellitus, systemic 
hypertension, coronary artery disease, peripheral vascular disease, 
drug intake, family history of  vascular event, history of vascular risk 
factors like smoking, alcohol consumption, other form of tobacco use, 
high risk behavior, other addictions, were obtained. 
All the patients were examined according to proforma that 
included general and systemic examination. All the patients underwent 
a basic investigation protocol that included   
 Complete blood count. 
 Renal function test. 
 Blood sugar 
 Fasting lipid profile 
 Electrolytes 
 HIV serology(as applicable) 
 Urine analysis 
 CT Brain- Plain 
 Chest X-ray, Electrocardiogram, Echocardiography 
 Carotid Doppler 
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Trans cranial doppler was done through trans orbital window to 
assess carotid siphon, ophthalmic artery. MRI brain with MRA and 
DWI, CT angiogram of cerebral vessels had been done wherever 
indicated. Other laboratory tests such as serum homocysteine, 
fibrinogen, prothrombin time, partial activated thromboplastintime, 
anti nuclear antibodies, anticardiolipin antibody, Lupus anticoagulant 
were done in selected patients wherever  needed. 
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SUMMARY AND STUDY PROCEDURE 
Stroke & TIA Venous/ 
Haemorrhagic& 
(CT Brain) Posterior 
Circulation stroke 
Excluded 
Anterior circulation ischemic 
          Stroke / TIA 
 
 
Stroke subtyping (cortical / subcortical / 
watershed infarct) 
(CT Brain) 
 
 
Risk factor Analysis 
(History / Biochemistry) 
 
 
Cardiac Evaluation 
↓ 
 
 
 Normal Cardiac Status Abnormal cardiac status 
 
 ↓ ↓ 
 Extra Cranial Excluded 
 Carotid Doppler 
 Showing carotid disease 
 ↓ No 
 
 
          Yes                               
            ↓                               Excluded 
  Transcranial doppler 
 (MRA / CTA if affordable / indicated) 
            ↓ 
    Analysis 
42 
 
OBSERVATION AND RESULTS 
 
 Among the total 485 patients, 150 patients (30.9%) with 
posterior circulation stroke or venous infarcts, intra cerebral 
hemorrhage were excluded from the study. Remaining 335 patients 
were subjected to cardiac evaluation, of them 23 patients (6.8%) who 
showed cardiac abnormalities were excluded from the study. Out of 
the 312 patients only 70 patients who  showed carotid artery disease in 
carotid doppler  were enrolled in this study and  subjected to 
transcranial  doppler to study the intra cranial part of internal carotid 
artery involvement. 
1. Sex Distribution: n=70 
Male  : 58 (83%)                  Female  : 12 (17%) 
 
Chart 1. Gender distribution in carotid stroke. 
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2. Age Distribution: 
 The study showed mean age of male is 58 years and female is 
62 years. The eldest among males is 86years and that in female is 
71years. The youngest  in male is 35 years  and in female is 30 years. 
Age (Years) Percentage (%) 
<40 4 
41-50 15 
51-60 41 
61-70 33 
>70 7 
Total 100 
Table 1. Age distribution 
 
Chart 2. Age Distribution 
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3. Stroke Risk Factors 
 
Chart 3. Risk Factors for Carotid stroke. 
Most common risk factor seen among 70 patients is 
dyslipidemia which was present in 56 (80%) patients. 4 patients had 
only systemic hypertension, 2 patients had only diabetes , and 3 
patients had only dyslipidemia. The study also showed that 44patients 
had double risk factors. Among 44 patients 10 (15%) had Diabetes 
Mellitus and systemic hypertension, 34 patients (49%) had the habit of 
both smoking and drinking alcohol. 5 patients(7%) had all the 5 risk 
factors. 
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4. Clinical Presentations 
 Among the Clinical Presentation of 70 patients, ischemic stroke 
is seen in 63 patients (90%), 6 patients (9%) had transient ischemic 
attack and one patient (1%)  had ocular stroke. 
 
  
 
 
 
 
Table 2. Various Clinical Presentation of carotid disease. 
 
Chart 4. Clinical presentation 
0
10
20
30
40
50
60
70
80
90
100
Ischemic Stroke TIA Ocular Stroke
Clinical Presentation (%) 
        Clinical Presentation 
No of 
patients Percent 
Ischemic Stroke 63 90% 
Transient Ischemic Attack 6 9% 
Ocular Stroke 1 1% 
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5. Incidence of Transient Ischemic attack in Carotid Stenosis: 
 Study showed total number of 17 patients (24%) with transient 
ischemic attack, out of which 11 patients later reported with stroke and 
remaining 6 patients were normal without developing stroke. The 
remaining 53  out of 70 patients had experienced  stroke without 
preceeding transient ischemic attack. 
 
Table 3. Incidence of TIA 
 
 
 
 
 
  
Transient ischemic 
attack 
Intracranialstenosis  
(n-45) 
Intracranialstenosis 
(n-15) 
Yes 12 5 
No 33 10 
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6. Vascular Territory involved in Carotid Stroke: 
In Carotid Stroke, most commonly involved territory is middle 
cerebral artery territory which accounted for 45patients (64%) and the 
least affected territory is Ophthalmic Artery which accounted for one 
patient (1%) 
Vascular Territory Total Percent 
Anterior cerebral artery 6 9% 
Middle cerebral artery 45 64% 
Normal (TIA) 6 9% 
Ophthalmic artery 1 1% 
Watershed infarct 12 17% 
Table 4. Vascular territory involved in carotid disease
Chart 5. Vascular territories 
0 10 20 30 40 50 60 70
Middle cerebral artery
Watershed infarct
Anterior cerebral artery
Ophthalmic artery
Percent(%) 
percent
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7. Stroke subtype involved in Carotid Stenosis: 
 Out of 70 patients, 27 patients (39%) were affected with 
territorial infarcts, 21 (30%) patients were affected with subcortical 
infarcts and cortical and subcortical together accounted for 4 patients 
(6%). Under watershed infarct subtype external and internal ones 
accounted for  8 patients (11%) and 4 patients (6%) respectively.   
 
 
Subtype Total Percentage 
Territorial Infarct 27 39% 
Subcortical Infarct 21 30% 
Watershed Infract - External 8 11% 
No Infarct 6 9% 
Cortical + Subcortical Infarct 4 6% 
Watershed Infarct - Internal 4 6% 
 
Table 5. Stroke subtypes 
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8. Extracranial Carotid Stenosis and Stroke: 
 The study evaluated under percentage of stenosis which showed 
left unilateral stenosis in 28 patients (39%) closely followed by 
unilateral right stenosis in  23 patients (34%), and the remaining 27% 
affected bilaterally. 
Percentage of Stenosis 
Unilateral 
Bilateral Right Left 
No Stenosis (IMT > 1) 2 (3%) 0 (0%) 
19 (27%) 
< 50% 10 (15%) 8 (11%) 
50 - 69% 4 (6%) 12 (17%) 
70 - 99% 2 (3%) 3 (4%) 
100% 5 (7%) 5 (7%) 
 
Table 6. Distribution of Extra cranial Stenosis 
Less than 50% stenosis were found in 18 patients (26%).Of 
which 8  (11%) had left sided stenosis and 10  (15%) had right sided 
stenosis, 50-99% stenosis were found in 21 patients (30%) of which 6 
(9%) had left sided stenosis and 15 (21%) had right sided stenosis. 10 
patients (14%)  had complete (100%) occlusion 
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9. Comparison of extracranial stenosis with intracranial stenosis 
in stroke patients. 
Among the 70 patients, 19 showed extracranial stenosis. Out of 
which, 10 had 100% stenosis for whom intracranial stenosis dectection 
is not possible. In remaining 60 patients, intracranial stenosis was 
detected in 35. Among them, 5 had bilateral intracranial stenosis. The 
remaining 25 did not show intracranial stenosis.  
Extracranial Stenosis Intracranial Stenosis 
Percentage 
Number of 
Patients 
Yes No 
0 - 99% 60 35 25 
100% 10 Not Applicable 
Table 7. Split up of Extra and Intra cranial carotid stenosis 
10. Unilateral Stenosis and stroke: 
 
 Among the 60 patients, 41 (68%) had unilateral extracranial 
stenosis of which 19 (31%) showed unilateral intracranial stenosis, 
one (2%) showed  bilateral intracranial stenosis, 21 (35%)   did not 
show stenosis in the  intracranial part of internal carotid artery. 
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11. Bilateral Stenosis and stroke: 
 
Among the 60 patients, 19 (27%) had bilateral extracranial 
stenosis. Of which, 5 (8%)  had bilateral intracranial stenosis, 10 
(19%) had  unilatral intracranial stenosis of whom, 8 patients showed 
right sided stenosis and remaining 2 had left sided stenosis.  
 
Patients with Bilateral Stenosis 
Extra Cranial Portion 
(n - 70) 
Intra Cranial Portion 
(n - 60) 
 
19 (27%) 5 (8%) 
 
Table 8. Bilateral carotid disease 
 
12. Stroke subtype in bilateral Stenosis: 
   
  Among the 70 patients, 19 (27%) had bilateral 
extracranial carotid stenosis of which 6 (8%) had external watershed 
infarct, 5 (7%) had middle cerebral artery territorial infarcts, 4 (6%) 
had subcortical infarcts. 4 patients (6%) did not show infarct of whom, 
2  presented with monoparesis and 2 had  only Transient Ischemic 
Attack.  
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13. Stroke subtype in unilateral extra cranial carotid stenosis 
without Intra cranial stenosis: 
  Among the 70 patients, 25 (27%) had unilateral 
extracranial carotid stenosis  without  intracranial internal carotid 
artery stenosis of which 11 patients  (18%) showed territorial infarct 
involving middle cerebral artery, 9 (15%) had subcortical infarcts. 5 
(8%) had watershed infarcts of whom, 3 (5%) had external watershed 
infarct and 2 showed Internal watershed infarct. 
 
 
 
 
 
 
 
 
 
 
  
53 
 
Discussion 
 Stroke is the leading cause of mortality and long term disability 
in adults. Incidence and prevalence of stroke varies according to the 
racial and ethnic group studied. Various risk factors dyslipidemia, 
diabetes mellitus, hypertension are responsible for the development of 
stroke. Carotid artery atherosclerotic disease has been recognized as a 
major cause of stroke and is responsible for 20 to 50% of ischemic 
stroke. Several studies have demonstrated that certain subgroups of the 
general population, such as blacks, Hispanics, and Asians have 
significantly higher incidence rates of Carotid artery occlusive disease 
compared to whites. 
(9,10,12)
 
 Among the 70 patients who were included in the study, 83% of 
cases  were  males and  remaining 17% were females.This is  in line 
with another study done by Chin Sang Chun et al, from South Korea 
who had also showed 87.3% of male predominance.  
The  mean age of males and females are 58 years and 62 years 
respectively with the age ranging from 35-86 years in males  and 30-
71 years in females.  74% of patients are in the age group of 50 to 70 
years which is similar to that reported by Chin Sang Chun et al with  
mean age of 65.5 years and age range of 43-81 years. The  autopsy 
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study by Baker et al reported 66% of patients are in the age group of 
50 to 70 years
(50)
 
On analysing the risk factors in 70 patients, dyslipidemia has 
topped the list with 56 patients (80%), followed by smoking in 42 
patients (60%), alcohol in 36 patients (51%), Diabetes Mellitus in  29 
patients (41%), and finally systemic hypertension in  26 patients 
(37%). Many of them had more than one risk factors . Single risk 
factor was present in  only 9 patients. Out of which , 2 had diabetes 
mellitus, 4 had systemic hypertension and 3 had dyslipidemia. 
The study also showed that 44 patients had two risk factors. 
Among 44 patients 10 (15%) had Diabetes Mellitus and systemic 
hypertension, 34 (49%) had the habit of both smoking and alcohol 
consumption. 5 (7%) had all the five risk factors. 
Our study results are comparable with other studies. Arenillas, 
et al 
(49) 
has reported intracranial internal carotid stenosis has been 
associated with dyslipidemia especially with increased total 
cholesterol and it also revealed  that  elevated low density lipoprotein 
also a risk factor   for internal carotid stenosis.  
The North Manhattan stroke study demonstrated that higher 
prevalence of Diabetes Mellitus in 67%  and dyslipidemia in 62% of 
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patients with intracranial carotid stenosis when compared with extra 
cranial carotid stenosis in the study group of 714 patients.
(51)
 
Impact of Diabetes Mellitus in the development of  intracranial 
carotid stenosis also established in Wai Hong Chen et al who studied 
in chinese patients in the study group of 153,which showed 50% 
association.
(13).
 
The varied clinical presentations are, (90%) 63 patients 
developed ischemic stroke, followed by transient ischemic attack in 6 
patients (9%) and the least being ocular stroke which occured in 1 
patient (1%). 
On the basis of vascular territory involved, 45 patients (64%) 
had middle cerebral artery occlusion in which 12 showed multiple 
lesions in middle cerebral artery territory, which is followed by 
watershed infarct in 12 patients (17%) and transient ischemic attack  
in 6 patients (9%). Another  6 patients (9%)  had anterior cerebral 
artery infarct and the least being ophthalmic artery occlusion that was 
seen in 1 patient (1%). This pattern of involvement comparable with 
study by Lee et al, lesion patterns and stroke mechanism in 
atherosclerotic middle cerebral artery disease and early diffusion-
weighted imaging study among 63patients (62%) with middle cerebral 
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artery stenosis,32 patients showed  fragmented infarct in the middle 
cerebral artery territory.
(57)
 
In the  overall 70 patients, 17 (24%) experienced transient 
ischemic attack out of which 11patients (15%)  developed stroke and 
the remaining 6  (9%) did not develop stroke. In this study among 45 
patients who had intra cranial stenosis, 12 experienced transient 
ischemic attack. 5  out of 15 patients without  intracranial stenosis 
experienced transient ischemic attack. This shows that  incidence of 
transient ischemic attack is higher in patients with  intracranial 
stenosis  compared to extracranial stenosis.   
When categorised as sub types, the study revealed that the 
territorial infarct was the highest, accounting for 27 patients (39%), 
and subcortical infarct in 21 (30%), followed by external watershed 
infarcts in 8 patients (11%), internal watershed infarcts in 4 (6%), 
Normal imaging (transient ischemic attack)  in  6 patients (9%), and 
finally  combined cortical and subcortical involvement  in  4 (6%). 
Among the 70 patients, 19 (27%) had bilateral extracranial 
carotid stenosis of which 6 (8%) had external watershed infarct, 5 
(7%) had territorial infarcts involving middle cerebral artery, 4 (6%) 
had  subcortical infarcts. 4 patients (6%)  did not show any  infarct. Of 
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which, 2 patients  presented with monoparesis and 2 patients presented 
with only transient ischemic attack.  
25 patients (27%) had unilateral extracranial carotid stenosis  
without  intracranial internal carotid artery stenosis. Of which 11   
(18%) showed territorial infarct involving middle cerebral artery, 9 
(15%) showed subcortical infarcts. 5 (8%)  showed watershed infarcts 
of which 3 (5%) had external watershed infarct and 2 had internal 
watershed infarct. 
In this study an attempt was made to analyse the concordance 
and discordance of carotid artery disease between extracranial and 
intracranial part of internal carotid artery. 19 patients (27%) had 
bilateral stenosis as compared to the study conducted in Korea which 
showed 33%. Less than 50% stenosis were found in 18 patients (26%), 
50-99% stenosis were found in 21 patients (30%) of which 6 patients 
(9%) had left sided stenosis and 15  (21%) had right sided stenosis. 10 
patients (14%)  had complete occlusion. Only 3% had increased 
intima media thickness ratio of more than one, without stenosis in the 
extracranial internal carotid artery. 
Out of total 70 patients with extracranial Internal carotid artery 
disease examined, 10 patients showed complete (100%) occlusion of 
extra cranial vessels, who cannot be further assessed for intra cranial 
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stenosis. In the remaining 60 patients, 35 (58%) showed associated  
intracranial stenosis and in remaining 25 (42%), no intra cranial 
stenosis was  detected. 
In a similar but invasive study (CT angiogram) performed by 
Chin Sang Chun et al at South Korea, discordance was observed in 
56.3% of patients with extracranial stenosis. Out of 121 patients 
studied, concordance in 58 patients (47.9%) also revealed intracranial 
stenosis. 
      Among the 60 patients, 41 (68%) had unilateral extracranial 
stenosis of which 19 (31%) showed unilateral intracranial stenosis, 
1(2%) showed bilateral intracranial stenosis and had middle cerebral 
artery territorial stroke on the side of intracranial internal carotid 
stenosis . 21 patients (35%)   did not show stenosis in the  intracranial 
part of internal carotid artery. Remaining 19 patients (27%) had 
bilateral extracranial stenosis of which 5 (8%)  had bilateral 
intracranial stenosis, 10 (19%) had  unilatral intracranial stenosis. In 
them, 8 patients showed right sided stenosis and remaining 2  had left 
sided stenosis.  
Studies regarding combined intracranial & extracranial steno-
occlusive disease  is comparitively less. In a study on Taiwan chinese 
population by  Lui et al, 42.2% of patients had intra cranial and extra 
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cranial carotid artery disease. But  Feldmann et al, reported that only 
9%  in chinese population.
(9) 
Solberg et al, studied Cerebral atherosclerosis in Negroes and 
Caucasians from New Orleans, Jamaica and Norway. They performed 
2166 autopsies in blacks and whites  which showed  the increased 
occurrence of intracranial stenosisis in blacks 43% compared to 8.5% 
in whites.
(46)
 
Risk of stroke occurrence increases with increasing degree of 
stenosis in carotid artery. It is estimated that the annual risk of stroke 
occurrence increases by less than 1% in patients with <80% stenosis 
and 4.8%  in patients with >90% stenosis. Early intervention in 
patients with lesser degree of carotid artery stenosis will decrease the 
risk of future stroke. 
Transcranial doppler and carotid doppler are the best 
noninvasive and widely available screening tool for carotid stenosis. 
But the disadvantages of trans cranial doppler is that it is operator 
dependent technique and it is hampered by the 10-15% rate of 
inadequate temporal windows especially in older individuals. trans 
cranial doppler can be used as an initial imaging modality to exclude 
intracranial internal carotid artery stenosis. 
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Conclusion 
1. The common risk factors for carotid artery disease in our 
study are dyslipidemia, systemic hypertension, diabetes 
mellitus, smoking and alcohol consumption, in the order of 
occurrence. 
2. Incidence of  transient ischemic attack was high in patients 
with intracranial carotid artery disease indicating the need 
for intensive management of these patients to prevent 
morbidity and mortality 
3. The most common radiological presentation is the territorial 
infarct involving the middle cerebral artery territory 
followed by watershed infarcts. 
4. Most of the patients with extracranial internal carotid artery 
disease also had co-existing intracranial internal carotid 
artery disease which in turn may further lead to stroke. This 
emphasizes the need to search for intracranial disease in 
patients with extra cranial carotid artery disease. 
5. Transcranial doppler can be used as a noninvasive initial 
screening tool for detecting intracranial internal carotid 
artery stenosis before considering any invasive investigation. 
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 Comparison of extracranial with intra cranial 
carotid artery disease in ischemic stroke  
 
Name  :     IP no  :                   
Age/sex       :     MIN no : 
DOA  :     DOD  : 
Phone no :     Address : 
Occupation  : 
 
Complaint  : 
 
 
Present history: 
 
a) Time of onset of stroke : 
 
b) What were his preceding symptoms ? 
 
     c) How did the associated symptoms appear in chronology ? 
 i st symptom 
 ii nd symptom 
 iii rd symptom  
 ivth symptom 
 v th sympom 
 others 
    d) Sensorium at onset   LOC/FULLY CONSCIOUS/DROWSY  
 
  
    E ) Was speech disturbance noted at  the time of stroke ? 
When ? 
What type-   Expressive / Sensory     
Global        
Dysarthria  
Mutism 
     F)PAST HISTORY 
 H/O  TIA  No. Of episodes of TIA:  
   G) RISK FACTORS.   SINCE WHEN    ON TREATMENT               
 HTN 
 DM 
 CARDIAC DISEASE 
 Oral Pills 
 CLAUDICATION 
 DRUG ABUSE /OTHERS 
 H)    TYPE NUMBER DURATION 
 CIGARETTES 
 ALCOHOL 
 TOBACCO 
  I) DIET 
   VEG/NONVEG/EGG+VEG 
  J) What is the nature of work? Sedentary/moderate/heavy  exertion 
  k) What are  the associated diseases and systems involved? 
  CVS    SEIZURES 
  P/A    MOOD DISORDER 
  R/S    MIGRAINE/OTHER HEADACHES 
  PERIPHERAL VASCULAR DISEASE: 
  
  L) TREATMENT/DRUG HISTORY: 
  What drugs? 
  Is he regular? 
  Any side effects? 
CLINICAL EXAMINATION 
  
1) Markers of atherosclerosis:        Skin xanthomas /arcus/ xanthomata 
 
2) Carotid  bruit-   
 
 PULSE     Right  Left 
  Carotids 
   Brachial 
   Radial 
   Dorsalis pedis 
 
   B.P SUPINE  mmHg    
     STANDING  mmHg      
 
3) Waist/hip ratio 
 
4) Ocular fundus- HTN/DM RETINOPATHY 
 
5) Consciousness- NORMAL/ DROWSY/STUPOR/COMA 
 
6) Lobar functions 
  Frontal :  Attention 
    Apathy 
    Story recall 
    Judgement 
  Parietal  : Cortical sensation  
    Apraxia/Finger body gnosis/Neglect 
 
  Occipital : Vision 
      
  Temporal : Memory: verbal/  Visual 
7)Cranial nerves: 
  
  8) Motor system        
        RT   LT 
 BULK       UL 
   LL 
 TONE UL             
   LL 
  POWER   UL PROXIMAL 
   DISTAL 
   LL PROXIMAL 
   DISTAL 
 SUPERFICIAL REFLEXES  
   Plantar 
   Corneal 
   Abdominal 
 
DTR BJ TJ SJ    KJ       AJ 
R 
L 
        
GAIT: 
           
9)  Sensory 
 
10) Cerebellar Signs 
 
11) EP Signs 
 
12) Bladder /Bowel Symptoms 
 
13) Signs of meningeal irritation:   Neck Rigidity/Kernig’s sign 
  
14) Other systems 
  
 CARDIO VASCULAR SYSTEM:      
  
 RESPIRATORY   SYSTEM: 
   
 ABDOMEN: 
 
15)CLINICAL DIAGNOSIS: 
 
      
 INVESTIGATIONS 
 
Complete haemogram: 
   
TC :         Cells/c mm Urea     :            mg/dl URINE R/E 
DC : P    %L   %E    % Creatinine :       mg/dl    
HB  :                 gms% SODIUM:         Meq/L HIV: 
PCV :                 % potassium:         meq/l  
Platelet:       lakhs/ mm
3
 cholesterol:       mg/dl VDRL: 
ESR :               mm/hr HDL:                mg/dl  
SUGAR :        mgs/dl TGL:                 mg/dl OTHERS 
 
 
 
 Cardiac evaluation: 
   
   ECG 
   C X R   PA  VIEW  
   Echocardiography: 
    Ejection fraction: 
    Wall motion abnormality: 
    Clot: 
 
Other investigations: 
 
 
 
 
 
 
 
 
 CAROTID DOPPLER  STUDY 
 
The intima medial thickness in common carotid artery and internal 
carotid  artery RT-      mm, LT-      mm 
 
 
PLAQUE  Location: 
   Ulceration: Yes/No 
   Calcification: Yes/No 
   Measures:                 mm 
   % Stenosis: 
  
IMPRESSION: 
 
 
TRANS CRANIAL DOPPLER 
 
IMPRESSION: 
 
 
CT ANGIOGRAM: 
ARTERY RT PSV RTEDV LT PSV LT EDV PLAQUE 
CCA 
(PROXIMAL) 
     
CCA(DISTA)  
 
    
ICA  
 
    
ECA  
 
    
CAROTID 
INDEX 
 
 
    
PARAMETERS RT CS LT CS RT  OA LT OA 
PEAK     
MEAN     
DIAS     
PI     
RI     
HR     
 CT BRAIN 
   
 
   
       
FINDINGS: 
 
 
 
 
     MRI BRAIN 
 
          T1     T2 T2 FLAIR DIFFUSION 
 
 
 
 
 
 
 
 
 
 
 
   
 
MRA : 
 
 
IMPRESSION: 
 NIHSS SCALE 
  
ITEM NAME       RESPONSE SCORE   
IA LOC Alert 
Not alert,obtunded 
Unresponsive 
0 
2 
3 
  
IB LOC 
QUESTIONS 
Answers both correctly 
Answers one correctly 
Answers neither correctly 
0 
1 
2 
  
IC LOC 
COMMANDS 
Performs both facts correctly 
Performs one fact correctly 
Performs neither facts correctly 
0 
1 
2 
  
2 GAZE Normal 
Partial gaze palsy 
Total gaze palsy 
0 
1 
2 
  
3 VISUAL FIELDS No visual loss 
Partial hemianopia 
Complete hemianopia 
 
0 
1 
2 
  
4 FACIAL PALSY Normal 
Minor paralysis 
Partial paralysis 
Complete paralysis 
0 
1 
2 
3 
  
5 MOTOR ARM 
    A.LEFT 
    B.RIGHT 
No drift 
Drift before 10 sec 
Fall before  10 sec 
No effort against gravity 
No drift movements 
0 
1 
2 
3 
4 
  
6 MOTOR LEG 
    A.LEFT 
    B.RIGHT 
No drift 
Drift before 5 sec 
Fall before 5 sec 
No effort against gravity 
No movement 
0 
1 
2 
3 
4 
  
7 ATAXIA Absent 
One limb 
Two limbs 
0 
1 
2 
  
8 SENSORY Normal 
Mild loss 
Severe 
0 
1 
2 
  
9 LANGUAGE Normal 
Mild aphasia 
Severe aphasia 
Mute or global aphasia 
0 
1 
2 
3   
  
10 DYSARTHRIA Normal  
Mild 
Severe 
0 
1 
2 
  
11 EXTINCTION / 
INATTENTION 
Normal  
Mild 
Severe 
0 
1 
2 
  
  TOTAL 42   
S.No Age Sex Presentation vascular territory subtype TIA DM SHT Smoking Alcohol Dyslipidemia Extracranial Carotid Stenosis Intracranial Carotid Stenosis
1 65 M R HP,GA MCA TI Yes Yes Yes Yes Yes Yes E and F Yes R
2 60 M R HP,WA MCA TI No No No No No Yes D Yes L
3 55 M R HP,GA WS EWS No No No Yes Yes Yes B Yes L
4 30 F R HP WS IWS No No No No No No D No
5 36 M L HP MCA TI No No No No Yes Yes A No
6 60 M R HP MCA TI No No Yes Yes Yes Yes D No
7 55 M L HP HS HA MCA TI No No No Yes Yes Yes A No
8 55 M R HP GA MCA TI No No No Yes Yes Yes H NA
9 52 M L HP HS MCA SC No No No Yes Yes Yes A No
10 75 M L HP MCA SC No Yes Yes Yes Yes Yes C Yes R
11 50 M R HP MCA SC No Yes No Yes Yes Yes B and C Yes both
12 57 M BA MCA TI No No No Yes Yes No C No
13 65 M R HP GA MCA TI Yes Yes No No No Yes A and B Yes L
14 63 M R HA MCA SC No Yes No No No Yes F Yes L
15 45 M L BMP NORMAL NI No Yes No Yes Yes Yes E and F Yes R
16 60 M R HP WS EWS No No No Yes No Yes B and C No
17 46 M R HP VL MCA SC No Yes No Yes Yes Yes B No
18 56 M R HA MCA SC No Yes Yes Yes Yes Yes D No
19 56 M TIA NORMAL NI Yes Yes No No No No E and F Yes R
20 61 M L HP HS HA MCA TI No No No Yes No No B No
21 68 F R HP SEIZURE WS EWS Yes No Yes No No Yes D and E No
22 58 F R HP ACA SC No No Yes No No No A and D No
23 45 M L HP MCA TI No No No Yes No Yes A Yes R
24 86 M R HP GA MCA TI Yes Yes Yes Yes Yes Yes D No
25 60 M R HP MCA TI No No No Yes Yes Yes H NA
26 65 M TIA NORMAL NI Yes No Yes No No No G NA
27 52 M L VL WA WS EWS Yes Yes No Yes No No E and H Yes Both
28 65 F R HP HS WS IWS No Yes Yes No No Yes B Yes L
29 54 M L BMP ACA SC No No No Yes Yes Yes A No
30 58 M R HA MCA SC No No Yes Yes Yes Yes D No
31 70 F R CMP ACA TI No Yes Yes No No Yes I Yes R
32 42 M L HP MCA TI SC Yes Yes No Yes Yes Yes G NA
33 50 M L HP MCA TI SC No Yes No No No Yes G NA
34 65 M R HP MCA  SC No No Yes No No Yes E Yes both
35 60 M R HP MCA  SC No No Yes No No Yes E Yes R
36 35 M  L VL OA TI Yes Yes No Yes Yes Yes C and H Yes R   L-NA
37 55 F R HP MCA SC No No Yes No No Yes F No
38 65 F R HP,GA MCA TI Yes Yes Yes No No Yes E and D Yes both
39 60 M R HP,WA MCA TI No Yes No No No Yes D Yes L
40 65 M R HP,GA WS EWS No Yes No Yes Yes Yes B Yes L
41 65 F R HP WS IWS No Yes No No No No D No
42 56 M L HP MCA TI No Yes No No Yes Yes A No
43 66 M R HP MCA TI No No Yes Yes Yes Yes D No
44 66 M L HP HS HA MCA TI No No No Yes Yes Yes A No
MASTER CHART
45 55 M R HP GA MCA TI No Yes No Yes Yes Yes H NA
46 57 M L HP HS MCA SC No No No Yes Yes Yes A No
47 76 M L HP MCA SC No No Yes Yes Yes Yes C No
48 54 M R HP MCA SC No No No Yes Yes Yes B and C Yes both
49 62 M BA MCA TI No No No Yes Yes No C No
50 66 M R HP GA MCA TI Yes No No No No Yes A and B Yes L
51 65 M R HA MCA SC No No No No No Yes F Yes L
52 47 M L BMP NORMAL NI No Yes No Yes Yes Yes E and F Yes R
53 62 M R HP WS EWS No Yes No Yes No Yes B and C No
54 47 M R HP VL MCA SC No No No Yes Yes Yes B Yes L
55 58 M R HA MCA SC No Yes Yes Yes Yes Yes D Yes L
56 59 M TIA NORMAL NI Yes No No No No No E and F Yes R
57 62 M L HP HS HA MCA TI No No No Yes No No B No
58 67 F R HP WS EWS Yes Yes Yes No No Yes D and E Yes R
59 58 F R HP ACA SC No No Yes No No No A and D Yes R
60 48 M L HP MCA TI No No No Yes No Yes A Yes R
61 84 M R HP GA MCA TI Yes No Yes Yes Yes Yes D Yes L
62 61 M R HP MCA TI No Yes No Yes Yes Yes H NA
63 66 M TIA NORMAL NI Yes Yes Yes No No No G NA
64 53 M L VL WA WS EWS Yes No No Yes No No E and H Yes Both
65 66 F R HP HS WS IWS No No Yes No No Yes B Yes L
66 55 M L BMP ACA SC No Yes No Yes Yes Yes A Yes R
67 57 M R HA MCA SC No No Yes Yes Yes Yes D Yes L
68 71 F R CMP ACA TI No No Yes No No Yes I Yes R
69 44 M L HP MCA TI SC Yes No No Yes Yes Yes G NA
70 55 M R HP MCA TI SC No No Yes No No Yes H NA
A- Right less than 50% stenosis R- Right SHT-Systemic Hypertension
B- Left less than 50% stenosis L-Left GA-Global aphasia
C- Right 50%-69% stenosis HP-Hemi Paresis ACA-Anterior Cerebral Artery
D- Left 50%-69% stenosis HS-Hemi Sensory Impairment MCA-Middle Cerebral Artery
E- Right 70%-99% stenosis VL-Visual Loss OA  -Ophthalmic Artery
F- Left 70%-99% stenosis CMP-Crural Mono Paresis TI    -Territorial Infarct
G-100% stenosis BMP_Brachial monoparesis WS-Water Shed Infarct
H- 100% stenosis HA-Hemi Ataxia IWS-Internal -Water Shed Infarct 
I - IMT Ratio more than 1 BA-Brocas Aphsis EWS-External -Water Shed Infarct
WA_Wernickes aphasia SC -Sub Cortical Infarct
TIA-Transient Isheamic Attack NA-Not Applicable
DM_Diabetes Mellitus NI - Negative Imaging
 
 
 
 
 
